Navigation Links
West Acquires Drug Delivery Assets From Plastef Investissements SA
Date:7/7/2009

LIONVILLE, Pa., July 7 /PRNewswire-FirstCall/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that it has purchased the drug delivery device business assets of Plastef Investissements SA. Under the agreement West has obtained the right to manufacture the eris safety syringe, a passive safety system for use with fixed, or staked, needle prefillable syringes. Operations will continue at Plastef's production facility located in Le Vaudreuil, Normandy, France, which has approximately 75 employees.

The eris system for staked needle syringes complements West's NovaGuard(TM) passive safety needle, which it recently introduced to the market for use with luer-lock syringes.

Financial terms of the transaction were not disclosed. The acquisition is expected to increase West's sales revenue by an estimated $5 million to $7 million over the remainder of 2009, and the acquisition is not expected to materially affect the Company's fully diluted earnings per share this year.

About West

West is a global manufacturer of components and systems for injectable drug delivery, including stoppers and seals for vials, and closures and disposable components used in syringe, IV and blood collection systems. The Company also provides products with application to the personal care, food and beverage markets. Headquartered in Lionville, Pennsylvania, West supports its partners and customers from 50 locations throughout North America, South America, Europe, Mexico, Japan, Asia and Australia. For more information, visit West at www.westpharma.com.

    Contacts:                            Investors and Financial Media:
    West                                 FD
    Michael A. Anderson                  Evan Smith / Theresa Kelleher
    Vice President and Treasurer         (212) 850-5600
    (610) 594-3345                       wst@fd.com


'/>"/>
SOURCE West Pharmaceutical Services, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Emdeon Acquires eRx Network, LLC
2. Hyland Software Acquires Valco Data Systems
3. Dental Network of America (DNoA) Acquires DenteMax, Owned by Blue Cross Blue Shield of Michigan
4. Euro RSCG Life Acquires Medicom Group to Further Strengthen Its Global and European Medical Education Offering
5. Orochem Technologies Acquires Oligonet, a Custom Oligo Synthesis Business
6. Beverages Holdings, LLC Acquires Bossa Nova: The Superfruit Company
7. Gentiva(R) Health Services Acquires Louisiana Home Health Agency
8. Doctor Diabetic Supply, Inc. Acquires Diabetes Source Rx
9. Genomma Lab Internacional Acquires Brands Flor de Naranja Sanborns(MR), Teatrical and Henna Egipcia From Grupo Sanborns
10. MD On-Line Inc. Acquires Medical Claim Corp.
11. WeissComm Group Acquires Common Sense Media Group, Appoints Founder Bob Pearson Chief Technology and Media Officer to Help Clients Evaluate and Optimize Social Media
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... , ... March 28, 2017 , ... ... plans work, the Self-Funding Success website has recently developed and published an informational ... Plans ” was created based on common inquiries the site’s team of third ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... Liu of SkyLex Advanced Surgical, Inc. is thrilled to offer the recently FDA-approved ... procedure, and this procedure adds to SkyLex Advanced Surgical’s already comprehensive list ...
(Date:3/28/2017)... ... 28, 2017 , ... Oily skin is a common and unwelcomed occurrence in people of all ... lot to offer to the discussion of dealing with excess skin oil. “Oily skin is ... home remedies that can help remove the oily shine while keeping the skin fresh and ...
(Date:3/27/2017)... Aurora, CO (PRWEB) , ... March 27, 2017 , ... ... Dr. Mark Braasch for leading sleep apnea treatment, with or without a referral. Sleep ... the condition, which can include daytime sleepiness, morning headaches and chronic snoring. , ...
(Date:3/27/2017)... ... March 27, 2017 , ... Biotechnology and ... and engagement over the household brands of Top-20 pharma by optimizing clinical trial ... partnering with the right outsourcing payments provider can provide the technology, infrastructure, and ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... Elysium Health joins major pharmaceutical companies to ... Cambridge academic scientists through ... Institute today announces Elysium Health as a partner to the ... collaborative projects with academic researchers in Cambridge ... major research investment outside the U.S. for the ...
(Date:3/27/2017)... 27, 2017 Summary This ... Eli Lilly and its partnering interests and activities since 2010. ... provides an in-depth insight into the partnering activity of one ... demand company reports are prepared upon purchase to ensure inclusion ... The report will be delivered in PDF format ...
(Date:3/27/2017)... -- ImMAGE Biotherapeutics (OTCMKTS: IMMG), an early-stage biotechnology company, announced ... efficacy studies. The company is harnessing the power of ... A, in an effort to find a better treatment ... 4 weeks of treatment in transgenic mice, the lead ... a full toxicology report of various organs. Cytotoxic T-cells ...
Breaking Medicine Technology: